Calaguan, Rhandy Jr P.
HRN: 26-84-30 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2025
CEFUROXIME 1.5GM (VIAL)
03/20/2025
03/20/2025
IV
1.5
OCTOR
Inguinal Hernia, Left
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary TractSkin & Soft TissueIntra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes